» Articles » PMID: 17085014

STAT1 As a Key Modulator of Cell Death

Overview
Journal Cell Signal
Date 2006 Nov 7
PMID 17085014
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors that mediate various biological responses, including cell proliferation, survival, apoptosis, and differentiation. Among the members of the STAT family, accumulating evidence now indicates an important role for STAT1 in various forms of cell death. Depending upon stimuli or cell types, STAT1 can modulate a broad spectrum of cell death, comprising both apoptotic and non-apoptotic pathways. STAT1-dependent regulation of cell death is largely dependent on a transcriptional mechanism such as the activation of death-promoting genes. However, non-transcriptional mechanisms such as STAT1 interaction with TRADD, p53, or HDAC have been implicated in the regulation of cell death by STAT1. Furthermore, STAT1 itself is also subject to complex forms of regulation such as post-translational protein modification, which can critically affect STAT1 signaling and STAT1-dependent cell death. Given the reports showing that dysregulation of STAT1 signaling is associated with various pathological conditions, including the development of cancer, a better understanding of the mechanism underlying STAT1 regulation of cell death may lead to successful strategies for targeting STAT1 in such pathological settings.

Citing Articles

E3 ligase MIB1 regulates STAT1/P21 signaling via regulation of FGFR1 in colorectal cancer.

Jung C, Park J, Seo S Genes Genomics. 2025; .

PMID: 40063182 DOI: 10.1007/s13258-025-01629-8.


Role of miRNAs in Apoptosis Pathways of Immune Cells in Systemic Lupus Erythematosus.

Azizan A, Farhadi E, Faezi S, Jamshidi A, Alikhani M, Mahmoudi M Immun Inflamm Dis. 2025; 13(2):e70124.

PMID: 39912562 PMC: 11800236. DOI: 10.1002/iid3.70124.


Deubiquitinase MYSM1 drives myocardial ischemia/reperfusion injury by stabilizing STAT1 in cardiomyocytes.

Shi X, Xu J, Liu L, Zhao S, Qian Y, Fang Z Theranostics. 2025; 15(5):1606-1621.

PMID: 39897566 PMC: 11780537. DOI: 10.7150/thno.100097.


STAT1 as a potential therapeutic target to treat bladder cancer.

Zhang Q, Fu S, Li X, Wang H, Wang J Int J Clin Exp Pathol. 2024; 17(9):298-307.

PMID: 39399655 PMC: 11470427. DOI: 10.62347/HYCN1717.


Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma.

Sayed Amr K, Mohamed Ezzat W, Ibrahim Saleh A, Heiba A, Amin H, Refaat Kamel R J Genet Eng Biotechnol. 2024; 22(3):100394.

PMID: 39179317 PMC: 11214395. DOI: 10.1016/j.jgeb.2024.100394.